Nanotechnology: Breaking the Current Treatment Limits of Lung Cancer

Shilin Li1,2, Shanshan Xu3, Xiaoyu Liang1,4

  • 1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, 100190, P. R. China.

Insights

Nanotechnology offers advanced solutions for lung cancer treatment, overcoming limitations of traditional methods and drug resistance in targeted therapy and immunotherapy. This approach enhances drug delivery and enables multimodal treatment strategies.

Area of Science:

  • Oncology
  • Materials Science
  • Biotechnology

Background:

  • Lung cancer presents significant morbidity and mortality challenges.
  • Traditional treatments have limitations including postoperative risks and systemic toxicity.
  • Targeted therapy and immunotherapy show promise but face drug resistance issues.

Purpose of the Study:

  • To summarize breakthroughs in nanotechnology for lung cancer treatment.
  • To highlight the importance of nanotechnology in overcoming current therapeutic challenges.
  • To review the integration of nanotechnology with targeted therapy and immunotherapy.

Main Methods:

  • Review of current literature on nanotechnology applications in lung cancer.
  • Analysis of nanoparticle properties relevant to drug delivery and multimodal therapy.
  • Synthesis of findings on targeted therapy and immunotherapy advancements.

Main Results:

  • Nanoparticles offer high surface area for drug delivery, reducing systemic toxicity.
  • Nanotechnology enables the development of multifunctional nanomedicines.
  • Photoelectric properties of nanoparticles facilitate multimodal lung cancer treatment.

Conclusions:

  • Nanotechnology is crucial for advancing lung cancer treatment.
  • Integrating nanotechnology with targeted therapy and immunotherapy is essential.
  • Nanomedicines provide a promising avenue for improved lung cancer outcomes.